Encouraged by quick recovery after kidney cancer

Diagnosed with kidney cancer after multiple abdominal surgeries, cryoablation allowed David to get back to the life he loves.

Read David's story

Press Releases
May 19, 2026
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease MARLBOROUGH,...

Apr 26, 2026
Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and...

Apr 15, 2026
Boston Scientific announces €75 million investment to expand R&D capabilities in Galway

GALWAY, Ireland, 15 April 2026 - Boston Scientific Corporation (NYSE: BSX) – a global leader in medical device technology – today announced a €75 million investment in its Galway site,...

Read more press releases

In the News
May 19, 2026
EuroPCR 2026: Seismiq 4CE IVL catheter meets endpoints in FRACTURE trial
Cardiovascular News
Results from the pivotal FRACTURE trial presented at EuroPCR 2026 showed that Boston Scientific’s investigational SEISMIQ 4CE coronary intravascular lithotripsy catheter met its primary safety and effectiveness endpoints, supporting its potential as a new treatment option for severely calcified coronary lesions during complex PCI procedures.
Apr 29, 2026
Persistent atrial fibrillation: pulsed field ablation as a first-line strategy
Pharma Star
New data from the AVANT GUARD study suggest that pulsed field ablation (PFA) may be an effective first-line treatment for persistent atrial fibrillation, reducing arrhythmia recurrence compared with antiarrhythmic drug therapy and supporting earlier intervention in selected patients.
Apr 8, 2026
Pulsed field ablation for cardiac arrythmias: innovating for the future
Hospital Healthcare Europe
Pulsed field ablation is emerging as a promising innovation in the treatment of cardiac arrhythmias. By offering a more targeted approach with the potential for improved safety and efficiency, the technology represents a significant step forward in the evolution of electrophysiology care.
Mar 19, 2026
A new era for kidney cancer care?
Health Tech World
Advances in technology and treatment approaches are ushering in a new era for kidney cancer care. From earlier detection to more targeted therapies, innovation is reshaping how the disease is managed and offering new hope for improved patient outcomes.

Read more news

2025 Impact Reporting

Advancing science for more innovative care, empowered people and a more sustainable future.

Learn about our impact

 

Media centre

Imagery and other resources

Top